National Biological Draws Warning for Nonconformance, Complaints

The GMP Letter
A A
The FDA warned National Biological Corp. for failure to thoroughly investigate complaints and improper handling of out-of-spec products.

To View This Article:

Login

Subscribe To The GMP Letter